- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 38.87M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 30.43M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$3.23M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$1.25M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $42.47M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $38.92M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $79.15M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $66.25M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $17.64M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $259.82K |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $594.66K |
| Current Assets | Q1 2026 · Mar 31, 2026 | $59.74M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $43.82M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $79.41M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $66.84M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.20 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.20 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.16K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.42K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$6.15M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$308.6K |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$308.6K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$5.02M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$307.7K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $512.88K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $83.66K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.67M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $75.97K |
| Revenue | Q1 2026 · Mar 31, 2026 | $2.18M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $159.63K |
| Capex | Q1 2026 · Mar 31, 2025 | $17.29M |